Literature DB >> 12677145

NF-kappaB regulates intestinal epithelial cell and bile salt-induced migration after injury.

Eric D Strauch1, Barbara L Bass, Jaladanki N Rao, Jennifer A Vann, Jian-Ying Wang.   

Abstract

OBJECTIVE: To determine if NF-kappa B regulates intestinal epithelial cell migration and if it has a role during bile salt-induced migration. SUMMARY BACKGROUND DATA: Mucosal restitution is an important repair modality in the gastrointestinal tract. The authors have shown that taurodeoxycholate (TDCA) increases intestinal epithelial cell migration. NF-kappa B regulates activation of a number of genes involved in inflammatory responses.
METHODS: Studies were conducted in IEC-6 cells. I kappa B protein expression was determined by Western blot analysis. Sequence-specific NF-kappa B binding activity was measured by EMSA shift assays and nuclear localization by immunohistochemistry. Cell migration was examined by using an in vitro model that mimics the early cell division-independent stages of epithelial restitution.
RESULTS: The process of cell migration over the wounded area was associated with a significant increase in NF-kappa B binding activity in IEC-6 cells. Immunohistochemistry revealed translocation of NF-kappa B into the nucleus. Western blot analysis showed that injury decreased I kappa B protein expression. Inhibition of the binding activity by treatment with a specific NF-kappa B inhibitor, MG-132, inhibited cell migration during restitution. Further, exposure to TDCA at the physiologic concentration that induces intestinal epithelial cell migration increased NF-kappa B binding activity, induced NF-kappa B translocation into the nucleus, and decreased I kappa B protein expression. MG-132 also inhibits bile salt-induced cell migration.
CONCLUSIONS: NF-kappa B regulates intestinal epithelial cell migration. Bile salts at physiologic concentrations increase cell migration by activation of NF-kappa B. These data show that bile salts may have a role in the maintenance of intestinal mucosal integrity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12677145      PMCID: PMC1514469          DOI: 10.1097/01.SLA.0000060459.03270.E7

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  42 in total

1.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

Review 2.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Bile salt stimulates intestinal epithelial cell migration through TGFbeta after wounding.

Authors:  E D Strauch; J Y Wang; B L Bass
Journal:  J Surg Res       Date:  2001-05-01       Impact factor: 2.192

5.  TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.

Authors:  H Hsu; J Huang; H B Shu; V Baichwal; D V Goeddel
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

6.  Combined modulation of the mesangial machinery for monocyte recruitment by inhibition of NF-kappaB.

Authors:  A Zernecke; K S Weber; C Weber
Journal:  Am J Physiol Cell Physiol       Date:  2001-12       Impact factor: 4.249

7.  NF-kappaB activation and susceptibility to apoptosis after polyamine depletion in intestinal epithelial cells.

Authors:  L Li; J N Rao; B L Bass; J Y Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-05       Impact factor: 4.052

Review 8.  The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection.

Authors:  C Jobin; R B Sartor
Journal:  Am J Physiol Cell Physiol       Date:  2000-03       Impact factor: 4.249

9.  Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway.

Authors:  F S Lee; J Hagler; Z J Chen; T Maniatis
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

10.  TRAF6 is a signal transducer for interleukin-1.

Authors:  Z Cao; J Xiong; M Takeuchi; T Kurama; D V Goeddel
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

View more
  13 in total

1.  Bile salts increase epithelial cell proliferation through HuR-induced c-Myc expression.

Authors:  Erin E Perrone; Lan Liu; Douglas J Turner; Eric D Strauch
Journal:  J Surg Res       Date:  2012-05-10       Impact factor: 2.192

2.  Dietary bile acid supplementation improves intestinal integrity and survival in a murine model.

Authors:  Erin E Perrone; Chen Chen; Shannon W Longshore; Oneybuchi Okezie; Brad W Warner; Chen-Chih Sun; Samuel M Alaish; Eric D Strauch
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

3.  Bile salts induce resistance to apoptosis through NF-kappaB-mediated XIAP expression.

Authors:  Douglas J Turner; Samuel M Alaish; Tongtong Zou; Jaladanki N Rao; Jian-Ying Wang; Eric D Strauch
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

4.  Taurodeoxycholate stimulates intestinal cell proliferation and protects against apoptotic cell death through activation of NF-kappaB.

Authors:  Alexander Toledo; Jon Yamaguchi; Jian-Ying Wang; Barbara L Bass; Douglas J Turner; Eric D Strauch
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

5.  ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis.

Authors:  Jakob Benedict Seidelin; Mehmet Coskun; Ben Vainer; Lene Riis; Christoffer Soendergaard; Ole Haagen Nielsen
Journal:  J Mol Med (Berl)       Date:  2013-02-01       Impact factor: 4.599

Review 6.  Intestinal bile acid physiology and pathophysiology.

Authors:  Olga Martinez-Augustin; Fermin Sanchez de Medina
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

7.  Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling.

Authors:  Avafia Y Dossa; Oswaldo Escobar; Jamie Golden; Mark R Frey; Henri R Ford; Christopher P Gayer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-25       Impact factor: 4.052

8.  Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.

Authors:  Orleâncio Gomes R Azevedo; Renato André C Oliveira; Bruna Castro Oliveira; Snjezana Zaja-Milatovic; Celina Viana Araújo; Deysi Viviana T Wong; Tiê Bezerra Costa; Herene Barros Miranda Lucena; Roberto César P Lima; Ronaldo A Ribeiro; Cirle A Warren; Aldo Ângelo M Lima; Michael P Vitek; Richard L Guerrant; Reinaldo B Oriá
Journal:  BMC Gastroenterol       Date:  2012-07-13       Impact factor: 3.067

Review 9.  Gut Microbiota in NSAID Enteropathy: New Insights From Inside.

Authors:  Xianglu Wang; Qiang Tang; Huiqin Hou; Wanru Zhang; Mengfan Li; Danfeng Chen; Yu Gu; Bangmao Wang; Jingli Hou; Yangping Liu; Hailong Cao
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

Review 10.  Secondary bile acids: an underrecognized cause of colon cancer.

Authors:  Hana Ajouz; Deborah Mukherji; Ali Shamseddine
Journal:  World J Surg Oncol       Date:  2014-05-24       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.